{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T12:59:39Z","timestamp":1788872379594,"version":"build-2803163510"},"reference-count":38,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2014,3,1]],"date-time":"2014-03-01T00:00:00Z","timestamp":1393632000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,3,1]],"date-time":"2014-03-01T00:00:00Z","timestamp":1393632000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","award":["W81XWH-11-1-0836"],"award-info":[{"award-number":["W81XWH-11-1-0836"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","award":["W81XWH-05-1-0527"],"award-info":[{"award-number":["W81XWH-05-1-0527"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofsurgicalresearch.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Surgical Research"],"published-print":{"date-parts":[[2014,3]]},"DOI":"10.1016\/j.jss.2013.09.039","type":"journal-article","created":{"date-parts":[[2013,10,2]],"date-time":"2013-10-02T13:40:26Z","timestamp":1380721226000},"page":"334-342","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["A totally recombinant human fibrin sealant"],"prefix":"10.1016","volume":"187","author":[{"given":"Mark A.","family":"Carlson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Calcaterra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason M.","family":"Johanning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iraklis I.","family":"Pipinos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Crystal M.","family":"Cordes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William H.","family":"Velander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jss.2013.09.039_bib1","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1046\/j.1423-0410.1997.7230133.x","article-title":"Fibrin sealant: scientific rationale, production methods, properties, and current clinical use","volume":"72","author":"Radosevich","year":"1997","journal-title":"Vox Sang"},{"key":"10.1016\/j.jss.2013.09.039_bib2","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1172\/JCI101527","article-title":"Chemical, clinical, and immunological studies on the products of human plasma fractionation. XX. A development of fibrin foam as a hemostatic agent and for use\u00a0in conjunction with human thrombin","volume":"23","author":"Bering","year":"1944","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jss.2013.09.039_bib3","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1002\/bjs.7235","article-title":"Randomized clinical trial of tranexamic acid-free fibrin sealant during vascular surgical procedures","volume":"97","author":"Chalmers","year":"2010","journal-title":"Br J Surg"},{"key":"10.1016\/j.jss.2013.09.039_bib4","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.2106\/00004623-199911000-00010","article-title":"The use of fibrin tissue adhesive to reduce blood loss and the need for blood transfusion after total knee arthroplasty. A prospective, randomized, multicenter study","volume":"81","author":"Levy","year":"1999","journal-title":"J Bone Joint Surg"},{"key":"10.1016\/j.jss.2013.09.039_bib5","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/S0022-5223(19)35324-3","article-title":"Randomized clinical trial of fibrin sealant in patients undergoing resternotomy or reoperation after cardiac operations. A multicenter study","volume":"97","author":"Rousou","year":"1989","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.jss.2013.09.039_bib6","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/j.jtcvs.2008.02.079","article-title":"Autologous fibrin sealant reduces the incidence of prolonged air leak and duration of chest tube drainage after lung volume reduction surgery: a prospective randomized blinded study","volume":"136","author":"Moser","year":"2008","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.jss.2013.09.039_bib7","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/S0140-6736(97)03233-9","article-title":"Randomized trial of single and repeated fibrin glue compared with injection of polidocanol in treatment of bleeding peptic ulcer","volume":"350","author":"Rutgeerts","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.jss.2013.09.039_bib8","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1016\/j.eururo.2007.04.027","article-title":"Efficacy and safety of TachoSil as hemostatic treatment versus standard suturing in kidney tumor resection: a randomized prospective study","volume":"52","author":"Siemer","year":"2007","journal-title":"Eur Urol"},{"key":"10.1016\/j.jss.2013.09.039_bib9","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1097\/01.sla.0000245846.37046.57","article-title":"Application of fibrin glue sealant after hepatectomy does not seem justified: results of a randomized study in 300 patients","volume":"245","author":"Figueras","year":"2007","journal-title":"Ann Surg"},{"key":"10.1016\/j.jss.2013.09.039_bib10","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1001\/archsurg.2010.62","article-title":"A prospective study of the efficacy of clinical application of a new carrier-bound fibrin sealant after liver resection","volume":"145","author":"Briceno","year":"2010","journal-title":"Arch Surg"},{"key":"10.1016\/j.jss.2013.09.039_bib11","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1136\/jramc-155-04-17","article-title":"Combat casualty care research at the U.S. Army Institute of Surgical Research","volume":"155","author":"Baer","year":"2009","journal-title":"J R Army Med Corps"},{"key":"10.1016\/j.jss.2013.09.039_bib12","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1097\/00005373-199908000-00002","article-title":"Dry fibrin sealant dressings reduce blood loss, resuscitation volume, and improve survival in hypothermic coagulopathic swine with grade V liver injuries","volume":"47","author":"Holcomb","year":"1999","journal-title":"J Trauma"},{"key":"10.1016\/j.jss.2013.09.039_bib13","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1001\/archsurg.1995.01430040082018","article-title":"Efficacy of a fibrin hemostatic bandage in controlling hemorrhage from experimental arterial injuries","volume":"130","author":"Larson","year":"1995","journal-title":"Arch Surg"},{"key":"10.1016\/j.jss.2013.09.039_bib14","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1097\/01.ta.0000251595.45451.d0","article-title":"The potential utility of fibrin sealant dressing in repair of vascular injury in swine","volume":"62","author":"Kheirabadi","year":"2007","journal-title":"J Trauma"},{"key":"10.1016\/j.jss.2013.09.039_bib15","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1097\/01.TA.0000075336.92129.27","article-title":"Advanced hemostatic dressing development program: animal model selection criteria and results of a study of nine hemostatic dressings in a model of severe large venous hemorrhage and hepatic injury in swine","volume":"55","author":"Pusateri","year":"2003","journal-title":"J Trauma"},{"key":"10.1016\/j.jss.2013.09.039_bib16","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1002\/jbm.b.30031","article-title":"Structural design of the dry fibrin sealant dressing and its impact on the hemostatic efficacy of the product","volume":"70B","author":"Pusateri","year":"2004","journal-title":"J Biomed Mater Res Part B"},{"key":"10.1016\/j.jss.2013.09.039_bib17","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1097\/00005373-199901000-00009","article-title":"Effect of dry fibrin sealant dressings versus gauze packing on blood loss in grade V liver injuries in resuscitated swine","volume":"46","author":"Holcomb","year":"1999","journal-title":"J Trauma"},{"key":"10.1016\/j.jss.2013.09.039_bib18","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1097\/01.ta.0000196672.47783.fd","article-title":"Making sense of the preclinical literature on advanced hemostatic products","volume":"60","author":"Pusateri","year":"2006","journal-title":"J Trauma"},{"key":"10.1016\/j.jss.2013.09.039_bib19","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1111\/j.1538-7836.2005.01365.x","article-title":"Fibrinogen and fibrin structure and functions","volume":"3","author":"Mosesson","year":"2005","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jss.2013.09.039_bib20","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.thromres.2003.10.010","article-title":"A comparison of fibrin sealants in relation to their in\u00a0vitro and in\u00a0vivo properties","volume":"112","author":"Dickneite","year":"2003","journal-title":"Thromb Res"},{"key":"10.1016\/j.jss.2013.09.039_bib21","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1182\/blood.V100.3.743","article-title":"Role of factor XIII in fibrin clot formation and effects of genetic polymorphisms","volume":"100","author":"Ariens","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.jss.2013.09.039_bib22","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1038\/nbt1026","article-title":"Production of recombinant protein therapeutics in cultivated mammalian cells","volume":"22","author":"Wurm","year":"2004","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.jss.2013.09.039_bib23","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1021\/bm301579p","article-title":"Recombinant human fibrinogen that produces thick fibrin fibers with increased wound adhesion and clot density","volume":"14","author":"Calcaterra","year":"2013","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.jss.2013.09.039_bib24","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1002\/phar.1128","article-title":"Safety and immunogenicity of recombinant human thrombin: a pooled analysis of results from 10 clinical trials","volume":"32","author":"Singla","year":"2012","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.jss.2013.09.039_bib25","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1182\/blood-2005-02-0788","article-title":"Safety and pharmacokinetics of recombinant factor XIII-A2 administration in patients with congenital factor XIII deficiency","volume":"108","author":"Lovejoy","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.jss.2013.09.039_bib26","series-title":"Applied Linear Statistical Models","author":"Neter","year":"1990"},{"key":"10.1016\/j.jss.2013.09.039_bib27","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1023\/A:1013810912609","article-title":"Secretory expression of the \u03b1-subunit of human coagulation factor XIII in the yeast Pichia pastoris","volume":"24","author":"Park","year":"2002","journal-title":"Biotechnol Lett"},{"key":"10.1016\/j.jss.2013.09.039_bib28","first-page":"3A","article-title":"Assays for determination of protein concentration","volume":"Appendix 3","author":"Olson","year":"2007","journal-title":"Curr Protoc Pharmacol"},{"issue":"Suppl 4","key":"10.1016\/j.jss.2013.09.039_bib29","first-page":"1","article-title":"The thromboelastography and the thromboelastograph technique","volume":"21","author":"Chandler","year":"1995","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.jss.2013.09.039_bib30","first-page":"895","article-title":"Swine models of hemorrhagic shock: to splenectomize or not to splenectomize, that is the question","volume":"67","author":"Devlin","year":"2009","journal-title":"J Trauma"},{"key":"10.1016\/j.jss.2013.09.039_bib31","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1006\/jsre.2000.5985","article-title":"Prevention of suture hole bleeding using fibrin sealant: benefits of factor XIII","volume":"93","author":"Dickneite","year":"2000","journal-title":"J Surg Res"},{"key":"10.1016\/j.jss.2013.09.039_bib32","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1006\/jsre.2002.6495","article-title":"The importance of factor XIII as a component of fibrin sealants","volume":"107","author":"Dickneite","year":"2002","journal-title":"J Surg Res"},{"key":"10.1016\/j.jss.2013.09.039_bib33","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1097\/BCR.0b013e31816673f8","article-title":"Efficacy and safety of a fibrin sealant for adherence of autologous skin grafts to burn wounds: results of a phase 3 clinical study","volume":"29","author":"Foster","year":"2008","journal-title":"J Burn Care Res"},{"key":"10.1016\/j.jss.2013.09.039_bib34","doi-asserted-by":"crossref","first-page":"2492","DOI":"10.1007\/s00464-008-9885-0","article-title":"The use of fibrin sealant to prevent major complications following laparoscopic gastric bypass: results of a multicenter, randomized trial","volume":"22","author":"Silecchia","year":"2008","journal-title":"Surg Endosc"},{"key":"10.1016\/j.jss.2013.09.039_bib35","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1002\/bjs.7646","article-title":"Randomized clinical trial of fibrin sealant\u00a0versus titanium tacks for mesh fixation in laparoscopic umbilical hernia repair","volume":"98","author":"Eriksen","year":"2011","journal-title":"Br J Surg"},{"key":"10.1016\/j.jss.2013.09.039_bib36","first-page":"S12","article-title":"The coagulopathy of trauma versus\u00a0disseminated intravascular coagulation","volume":"60","author":"Hess","year":"2006","journal-title":"J Trauma"},{"key":"10.1016\/j.jss.2013.09.039_bib37","doi-asserted-by":"crossref","first-page":"2479","DOI":"10.1182\/blood.V96.7.2479.h8002479_2479_2486","article-title":"Val34Leu polymorphism of\u00a0plasma factor XIII: biochemistry and epidemiology in familial thrombophilia","volume":"96","author":"Balogh","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.jss.2013.09.039_bib38","unstructured":"Tisseel\u00ae Kit VH Baxter Fibrin Sealant Prescribing Information. http:\/\/www.rxmed.com\/b.main\/b2.pharmaceutical\/b2.prescribe.html. Accessed May 1,\u00a02013."}],"container-title":["Journal of Surgical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022480413009128?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022480413009128?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T14:41:20Z","timestamp":1758379280000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022480413009128"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,3]]}},"alternative-id":["S0022480413009128"],"URL":"https:\/\/doi.org\/10.1016\/j.jss.2013.09.039","relation":{},"ISSN":["0022-4804"],"issn-type":[{"value":"0022-4804","type":"print"}],"subject":[],"published":{"date-parts":[[2014,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A totally recombinant human fibrin sealant","name":"articletitle","label":"Article Title"},{"value":"Journal of Surgical Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jss.2013.09.039","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}